PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.08%
Revenue growth above 1.5x MRVL's 4.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
4.16%
Gross profit growth similar to MRVL's 3.82%. Walter Schloss would assume both firms track common industry trends.
2800.34%
EBIT growth above 1.5x MRVL's 8.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
2800.34%
Operating income growth above 1.5x MRVL's 15.99%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1.08%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
-15.38%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-15.38%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.25%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.83%
Reduced diluted shares while MRVL is at 1.17%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.28%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
8.56%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
11.00%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
87.72%
10Y revenue/share CAGR above 1.5x MRVL's 56.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
34.54%
5Y revenue/share CAGR under 50% of MRVL's 109.65%. Michael Burry would suspect a significant competitive gap or product weakness.
46.44%
3Y revenue/share CAGR above 1.5x MRVL's 25.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
30.37%
5Y OCF/share CAGR at 50-75% of MRVL's 45.44%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
13.89%
3Y OCF/share CAGR under 50% of MRVL's 63.72%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
473.10%
Net income/share CAGR at 50-75% of MRVL's 653.69%. Martin Whitman might question if the firm’s product or cost base lags behind.
370.76%
5Y net income/share CAGR above 1.5x MRVL's 220.76%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
303.98%
3Y net income/share CAGR 1.25-1.5x MRVL's 202.86%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
73.62%
10Y equity/share CAGR 1.25-1.5x MRVL's 54.87%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
9.94%
5Y equity/share CAGR at 50-75% of MRVL's 19.67%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
43.36%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
-25.54%
Cut dividends over 10 years while MRVL stands at 0.04%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-13.13%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-11.62%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-1.10%
Firm’s AR is declining while MRVL shows 11.24%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.38%
Inventory shrinking or stable vs. MRVL's 4.05%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.13%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.88%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-4.09%
We’re deleveraging while MRVL stands at 3.89%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.96%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.